Funding for nonmalignant hematology research available through the SHINE program to support innovative projects in collaboration with NIDDK, NIA, and NHLBI.
NHLBI plans to fund single-site clinical trials (R61/R33) testing therapeutic, behavioral, or prevention strategies, encouraging innovative designs.
NIDDK offers a Small Grant Program to enhance research capabilities of K01/K08/K23/K25 recipients as they transition to independent investigators.
Research grant for studying biological, behavioral, and social factors impacting HIV pathogenesis within NIDDK's mission and NIH priorities.
The New Investigator Research Grant Program by the Leukemia Research Foundation funds innovative early-career research projects in leukemia and myelodysplastic syndromes.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.